Company Overview
Option Care Health, Inc. operates as a specialized provider of home and alternate site infusion services throughout the United States, delivering critical therapies such as anti-infective treatment, heart failure management, and nutritional support for both acute and chronic conditions. The company functions within the broader Healthcare sector, specifically categorized under the Medical Care Facilities industry, positioning it as a key player in the decentralized delivery of medical care. This organization employs a workforce of 6,528 individuals to support its extensive service network, reflecting a substantial operational footprint. With a market capitalization of $4.62 billion and annual revenue of $5.65 billion, the company demonstrates significant scale that indicates a well-established position within the competitive landscape of home health care.
Financial Health
The company reported total revenue of $5.65 billion and net income of $207.58 million over the trailing twelve months, while generating EBITDA of $408.60 million. The substantial gap between the $5.65 billion in revenue and the $207.58 million in net income reveals a cost structure where operating expenses, including cost of goods sold and overhead, consume approximately 96.3% of total revenue before arriving at the bottom line. Free cash flow stands at $172.75 million, a figure that indicates the company retains sufficient liquidity to fund operations and potentially pursue strategic initiatives without relying exclusively on external financing. In terms of profitability efficiency, the gross margin is 19.3%, suggesting that nearly one-fifth of revenue remains after direct costs; the operating margin of 6.2% reflects the company's ability to cover overhead expenses; and the profit margin of 3.7% highlights the final net earnings available to shareholders after all expenditures. Regarding liquidity and leverage, the company holds $238.12 million in cash against total debt of $1.27 billion, resulting in a debt-to-equity ratio of 96.00%, which indicates a highly leveraged balance sheet where liabilities are nearly equal to equity. The current ratio of 1.52 suggests that the company possesses sufficient current assets to cover its short-term obligations, providing a buffer for immediate financial needs. Return on equity is 15.2% and return on assets is 6.1%, metrics that reveal management's effectiveness in generating profits from shareholder investments and utilizing the company's total asset base respectively.
Valuation Assessment
The trailing twelve-month P/E ratio is 22.94, while the forward P/E is 13.69, implying that the market expects earnings to grow significantly in the future to justify the lower multiple based on projected rather than historical performance. The price-to-book ratio stands at 3.44, indicating that the market values the company at more than three times its book value, which suggests investors are pricing in intangible assets, growth potential, or a premium over the net asset value. Alternative valuation metrics include a price-to-sales ratio of 0.82 and an EV/EBITDA of 13.69, figures that suggest the stock trades at less than one dollar of revenue per share of sales and offers an enterprise value relative to earnings before interest, taxes, depreciation, and amortization that is often considered reasonable for healthcare facilities. The stock has traded between a 52-week high of $36.80 and a 52-week low of $24.24, meaning the current valuation sits within this established historical range, providing context for recent price movements relative to volatility extremes. The beta value of 0.88 indicates that the stock's price volatility is lower than the broader market, suggesting it may be less sensitive to general market swings compared to high-beta equities.
Growth & Income
Revenue growth year-over-year is 8.8%, whereas earnings growth year-over-year is 1.3%, indicating that earnings are growing at a rate significantly slower than revenue, which implies that cost pressures or margin compression are currently outpacing top-line expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm reinvests its earnings back into the business rather than distributing cash to shareholders. This lack of dividend payouts aligns with the company's growth profile where capital is directed toward operational expansion and debt management rather than income generation. Overall, the company presents a growth-oriented financial profile characterized by double-digit revenue expansion but constrained earnings growth and no income distribution to investors.